Impellia, the sports medicine/technology venture by Charlie Batch and partners, announced this week that they have agreed to partner with the University of Michigan and the schools student athletes!

The story, covered by, reads in part:

“The two entities will be working together to analyze product data while the Pittsburgh-based startup Impellia receives feedback from University of Michigan staff and players around its software and sensor-based technologies. The exploratory partnership could see Impellia license its products to all 31 Division I Michigan athletics teams in the future.”

The article goes on to quote Charlie saying:

“We’re excited about the opportunities this mutually-beneficial endeavor will present. The core of Impellia’s mission is to play a significant role in the future of sports medicine technologies and their impact on player health, and this partnership presents us with a concrete opportunity to do just that.”

Read the full story on